Treatment of Athlete's Foot (Tinea Pedis)
Apply topical terbinafine 1% cream twice daily for 1 week as first-line treatment for athlete's foot. 1
First-Line Topical Therapy
Terbinafine 1% cream is the most effective topical agent, requiring only 1 week of twice-daily application compared to 4 weeks for other antifungals. 1 This shorter duration stems from terbinafine's fungicidal (rather than fungistatic) mechanism, which directly kills dermatophytes. 1, 2
- Terbinafine achieves 93.5% mycological cure at 4 weeks, significantly superior to clotrimazole's 73.1% cure rate despite clotrimazole requiring 4 weeks of treatment. 3
- Effective treatment rates reach 89.7% with terbinafine versus 58.7% with clotrimazole at 4 weeks. 3
Alternative Topical Options
If terbinafine is unavailable:
- Ciclopirox olamine 0.77% cream/gel applied twice daily for 4 weeks achieves approximately 60% cure at treatment end and 85% cure two weeks post-treatment. 1
- Clotrimazole 1% cream applied twice daily for 4 weeks is less effective than both terbinafine and ciclopirox but remains widely available over-the-counter. 1
- Miconazole topical preparations applied twice daily for 4 weeks are FDA-approved for athlete's foot, with particular attention to spaces between toes. 4
When to Use Oral Therapy
Reserve oral antifungals for severe disease, failed topical therapy, concomitant nail infection (onychomycosis), or immunocompromised patients. 1
Oral Treatment Options
- Oral terbinafine 250 mg once daily for 1-2 weeks provides similar mycological efficacy to 4 weeks of topical clotrimazole but with faster clinical resolution. 1 This is the preferred oral agent due to its fungicidal action and superior efficacy against dermatophytes. 1
- Oral itraconazole 100 mg daily for 2 weeks offers comparable efficacy to oral terbinafine but may have slightly higher relapse rates. 1 Itraconazole provides broader antifungal coverage including Candida and non-dermatophyte moulds, useful when mixed pathogens are suspected. 1
- Fluconazole is less effective than both terbinafine and itraconazole for dermatophyte infections but may be considered when other agents are contraindicated due to fewer drug interactions. 1
Safety Monitoring for Oral Terbinafine
- Obtain baseline liver function tests and complete blood count before initiating oral terbinafine in patients with hepatic disease or hematologic abnormalities. 1
- Monitor for rare but serious adverse events including isolated neutropenia and hepatic failure, particularly in those with pre-existing liver disease. 1
- Common side effects include headache, taste disturbance, and gastrointestinal upset. 1
Critical Prevention Measures to Prevent Recurrence
Failure to address these factors leads to treatment failure and reinfection:
Footwear Decontamination
- Contaminated shoes harbor large numbers of viable dermatophyte spores and are a major source of recurrence. 1
- Discard old, moldy footwear when possible. 1
- If shoes cannot be discarded, place naphthalene mothballs inside, seal in a plastic bag for minimum 3 days, then air out to markedly reduce fungal load. 1
- Spray terbinafine solution inside shoes periodically for additional antifungal protection. 1
Concomitant Nail Infection
- Always examine for onychomycosis (nail fungus), which requires extended oral terbinafine therapy (12-16 weeks) and serves as a reservoir for foot reinfection. 1
- Topical foot treatment alone will fail if nail infection is present. 1
Household Transmission
- Treat all infected family members simultaneously to prevent reinfection cycles. 1
- Avoid sharing toenail clippers and keep nails as short as possible. 1
Daily Hygiene Practices
- Thoroughly dry between toes after showering or bathing, as moisture promotes fungal growth. 1
- Change to cotton, absorbent socks daily, which reduces infection rates from approximately 8.5% to 2.1%. 1
- Apply antifungal foot powder after bathing for additional prevention. 1
- Wear protective footwear in public bathing facilities, gyms, and hotel rooms. 1
- Clean athletic footwear periodically to eliminate fungal elements. 1
Special Populations
Diabetic Patients
- Prefer terbinafine over itraconazole in diabetics due to lower risk of drug interactions and hypoglycemia. 1
- Up to one-third of diabetics have onychomycosis, which significantly predicts foot ulcer development. 1
Athletes
- Require minimum 72 hours of antifungal therapy before return to contact sports. 1
- Cover lesions with gas-permeable dressing followed by underwrap and stretch tape. 1
- Exclude from swimming pools and discourage barefoot walking in locker rooms until treatment initiated. 1
Common Pitfalls to Avoid
- Stopping treatment when symptoms improve but before mycological cure leads to relapse—the definitive endpoint should be mycological cure, not just clinical response. 5
- Treating only visible foot lesions without examining hands, groin, and body folds, as dermatophytes spread to multiple body sites in 25% of cases. 1
- Putting on underwear before socks, which can spread infection to the groin—always cover active foot lesions with socks first. 1